Main Content

Press Release
WKR: ELEKTA AND IMPAC MEDICAL SYSTEMS AGREE TO JOINTLY DEVELOP DICOM-RT LINEAR ACCELERATOR INTERFACE

ELEKTA AND IMPAC MEDICALSYSTEMS AGREE TO JOINTLY DEVELOP DICOM-RT LINEAR ACCELERATORINTERFACE

Interface will be the firstcomplete linear accelerator DICOM-RT interface and willfacilitate connectivity between Elekta’s digital linearaccelerators and IMPAC’s Oncology Management System

Elekta, a world-leading supplierof advanced and innovative radiation oncology solutions andservices, and IMPAC Medical Systems, Inc. (NASDAQ:IMPC), aleading provider of information management solutions for cancercare, announce today their agreement to use a full DICOM-RTcompliant specification for the development of an interface toconnect the Elekta product lines of digital linear accelerators (ElektaSynergy™ and Precise Treatment System™) with IMPAC’soncology information management products.

This interface will provide avendor-independent means of facilitating universal connectivityof next-generation radiation treatment devices, such as linearaccelerators and proton therapy delivery systems as well astreatment simulation devices to information management systems.IMPAC and Elekta are the first to formally adopt the standard.Both companies have been working together towards this goal overthe past months.

"This agreement will furtherimprove seamless connectivity for customers by expanding the useof new technology systems as well as shorten the start-up timefor new and expanding cancer centers ," stated TomasPuusepp, Executive VP Sales, Marketing & Service at Elekta."More importantly, patients will benefit from a more rapiddeployment of leading edge treatments. We encourage all oncologyvendors to join Elekta and IMPAC in adopting this standard."

"This is a collaborativedevelopment effort aimed at improving the process of managingincreasingly complex cancer treatment techniques," statedJoseph K. Jachinowski, president and CEO of IMPAC. "IMPAC isdelighted to team with Elekta in this agreement to adopt theDICOM-RT standard in a complete manner," he added.

For further information, pleasecontact:
International: Peter Ejemyr, Group VP CorporateCommunications, Elekta AB (publ),
Phone: +46 733 611 000, e-mail: peter.ejemyr@elekta.com

United States: Lars Jonsteg, VPInvestor Relations North America, Elekta, USA
Phone: +1 770-670-2419, e-mail: lars.jonsteg@elekta.com

About Elekta:
Elekta is a world-leading supplier of advanced and innovativeradiation oncology and neurosurgery solutions and services forprecise treatment of cancer and brain disorders. Elekta'ssolutions are clinically effective, cost efficient and gentle tothe patient.

For additional information aboutElekta, please visit www.elekta.com

About IMPAC Medical Systems
IMPAC Medical Systems, Inc. is a leading provider ofspecialized IT solutions that streamline both clinical andbusiness operations to help improve the process of deliveringquality patient care. With open integration to multiplehealthcare data and imaging systems, IMPAC offers a comprehensiveIT solution that includes specialized electronic charting, full-featuredpractice management, clinical laboratory management, and outcomesreporting. Supporting over 1600 installations worldwide, IMPACdelivers practical solutions that deliver better overallcommunication, process efficiency and quality patient care.

For more information about IMPACMedical Systems' products and services, please call +1-650-623-8800or visit www.impac.com.


This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download: